Literature DB >> 19106286

The prevalence of low triiodothyronine according to the stage of chronic kidney disease in subjects with a normal thyroid-stimulating hormone.

Sang Heon Song1, Ihm Soo Kwak, Dong Won Lee, Yang Ho Kang, Eun Young Seong, Jin Sup Park.   

Abstract

BACKGROUND: We hypothesized that the prevalence of low T3 would be increased according to the increase in CKD stage. This study was performed to explore the prevalence in each stage of CKD and relationship with eGFR.
METHODS: A total of 2284 cases with normal thyroid-stimulating hormone (TSH) level were enrolled and retrospectively analysed during the recent period, from July 2005 to December 2007.
RESULTS: There was an increasing trend for the population of low T3 according to the increase of a CKD stage (eGFR > or = 90, 8.2%; > or = 60 eGFR < 90, 10.9%; > or = 30 eGFR < 60, 20.8%; > or = 15 eGFR < 30, 60.6%; eGFR < 15, 78.6%). Also, there was positive relationship between eGFR and serum T3 in male, female and total subjects. After adjusting for age and sex, compared with eGFR > or = 60 ml/min/ 1.73 m2, eGFR < 60 ml/min/1.73 m2 was associated with an increased odds of low T3 [odds ratio 2.40 (CI: 1.5315 to 3.1731)]. In multiple regression analysis, eGFR was positively related with T3 (standardized coefficient 0.143, R2 = 0.055, P < 0.001), independent of age and serum albumin.
CONCLUSION: This study showed that low T3 syndrome was highly prevalent in CKD and was a remarkable finding in early CKD. Furthermore, serum T3 levels were associated with severity of CKD even in the normal TSH level.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19106286     DOI: 10.1093/ndt/gfn682

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  37 in total

1.  Associations of triiodothyronine levels with carotid atherosclerosis and arterial stiffness in hemodialysis patients.

Authors:  Erhan Tatar; Fatih Kircelli; Gulay Asci; Juan Jesus Carrero; Ozkan Gungor; Meltem Sezis Demirci; Suha Sureyya Ozbek; Naim Ceylan; Mehmet Ozkahya; Huseyin Toz; Ercan Ok
Journal:  Clin J Am Soc Nephrol       Date:  2011-08-11       Impact factor: 8.237

Review 2.  Nonthyroidal illness and the cardiorenal syndrome.

Authors:  Christiaan L Meuwese; Olaf M Dekkers; Peter Stenvinkel; Friedo W Dekker; Juan J Carrero
Journal:  Nat Rev Nephrol       Date:  2013-09-03       Impact factor: 28.314

3.  Low-T3 Syndrome in Peritoneal Dialysis: Metabolic Adaptation, Marker of Illness, or Mortality Mediator?

Authors:  Connie M Rhee
Journal:  Clin J Am Soc Nephrol       Date:  2015-05-15       Impact factor: 8.237

4.  The effect of TSH change per year on the risk of incident chronic kidney disease in euthyroid subjects.

Authors:  Da Young Lee; Jae Hwan Jee; Ji Eun Jun; Tae Hyuk Kim; Sang-Man Jin; Kyu Yeon Hur; Sun Wook Kim; Jae Hoon Chung; Moon-Kyu Lee; Jae Hyeon Kim
Journal:  Endocrine       Date:  2016-10-05       Impact factor: 3.633

5.  Low Triiodothyronine Syndrome and Long-Term Cardiovascular Outcome in Incident Peritoneal Dialysis Patients.

Authors:  Tae Ik Chang; Joo Young Nam; Sug Kyun Shin; Ea Wha Kang
Journal:  Clin J Am Soc Nephrol       Date:  2015-05-15       Impact factor: 8.237

Review 6.  The correct renal function evaluation in patients with thyroid dysfunction.

Authors:  Mariadelina Simeoni; Annamaria Cerantonio; Ida Pastore; Rossella Liguori; Marta Greco; Daniela Foti; Elio Gulletta; Antonio Brunetti; Giorgio Fuiano
Journal:  J Endocrinol Invest       Date:  2015-10-28       Impact factor: 4.256

7.  Baseline levels and trimestral variation of triiodothyronine and thyroxine and their association with mortality in maintenance hemodialysis patients.

Authors:  Christiaan L Meuwese; Friedo W Dekker; Bengt Lindholm; Abdul R Qureshi; Olof Heimburger; Peter Barany; Peter Stenvinkel; Juan J Carrero
Journal:  Clin J Am Soc Nephrol       Date:  2012-01       Impact factor: 8.237

Review 8.  Thyroid disease in end-stage renal disease.

Authors:  Connie M Rhee
Journal:  Curr Opin Nephrol Hypertens       Date:  2019-11       Impact factor: 2.894

Review 9.  Thyroid functional disease: an under-recognized cardiovascular risk factor in kidney disease patients.

Authors:  Connie M Rhee; Gregory A Brent; Csaba P Kovesdy; Offie P Soldin; Danh Nguyen; Matthew J Budoff; Steven M Brunelli; Kamyar Kalantar-Zadeh
Journal:  Nephrol Dial Transplant       Date:  2014-02-25       Impact factor: 5.992

10.  Thyroid hormone replacement therapy attenuates the decline of renal function in chronic kidney disease patients with subclinical hypothyroidism.

Authors:  Dong Ho Shin; Mi Jung Lee; Hye Sun Lee; Hyung Jung Oh; Kwang Il Ko; Chan Ho Kim; Fa Mee Doh; Hyang Mo Koo; Hyoung Rae Kim; Jae Hyun Han; Jung Tak Park; Seung Hyeok Han; Tae-Hyun Yoo; Shin-Wook Kang
Journal:  Thyroid       Date:  2013-05-28       Impact factor: 6.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.